Company / Profit Margin
aTYR PHARMA INC Profit Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-39009.5%
FY2025
5-year range
-39009.5% / -155.2%
FY2021-FY2025
Trend
-43.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -155.2% to -39009.5% over the past 3 years.
Based on SEC 10-K filings.
-39009.5% in FY2025 with a 5-year CAGR of -30830.6%.
Declined from -155.2% to -39009.5% over the past 3 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -38854.3pp
- 5-Year Change
- -30830.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 43.2% year-over-year.
- Peak profit margin was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -39009.5% | -43.2% |
| FY2024 | -27243.8% | - |
| FY2023 | - | - |
| FY2022 | -155.2% | +97.2% |
| FY2021 | -5593.1% | +31.6% |
| FY2020 | -8178.9% | +28.4% |
| FY2019 | -11423.5% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026